Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2012
12/27/2012WO2012177635A1 Metalloenzyme inhibitor compounds
12/27/2012WO2012177618A1 Prostaglandin receptor ep2 antagonists, derivatives, compositions, and uses related thereto
12/27/2012WO2012177606A1 Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as jak inhibitors
12/27/2012WO2012177603A2 Metalloenzyme inhibitor compounds
12/27/2012WO2012177593A2 Method for treating obesity
12/27/2012WO2012177565A2 Regulation of macrophage activation using mir - 125b
12/27/2012WO2012177433A1 Topical compositions for the treatment of dermatological disorders
12/27/2012WO2012177263A1 Compounds and methods of prophylaxis and treatment regarding nictonic receptor antagonists
12/27/2012WO2012177251A1 Pharmaceutical compositions comprising iodine and steroid and uses thereof for sinus diseases
12/27/2012WO2012177214A1 Liquid pharmaceutical composition comprising nitisinone
12/27/2012WO2012177151A1 Anti-parasitic composition comprising a macrocyclic lactone and levamisole and method of treatment of parasitic infestation
12/27/2012WO2012177135A1 Method for reducing the occurrence of infection in young children
12/27/2012WO2012177118A1 Method for reducing the occurrence of infection in young children
12/27/2012WO2012177100A2 Composition comprising phosphatidylcholine as an active ingredient for attenuating toxicity of anticancer agent
12/27/2012WO2012177075A2 Composition containing antibiotics and lysophosphatidylcholine for boosting immunity or treatment of bacterial infections
12/27/2012WO2012177008A2 Composition for controlling chromogenesis including microrna
12/27/2012WO2012176952A1 Aptamer which selectively binds to erbb2 receptor and uses thereof
12/27/2012WO2012176934A1 Crystal of fused heterocyclic compound
12/27/2012WO2012176878A1 Proteasome inhibitor
12/27/2012WO2012176862A1 Hydrophobic polymer compound having anticoagulant effect
12/27/2012WO2012176853A1 Protein comprising truncated form of extracellular domain protein of frizzled 2, and pharmaceutical composition for treating bone diseases which comprises said protein
12/27/2012WO2012176842A1 Reduced coenzyme q10 crystal having excellent stability
12/27/2012WO2012176823A1 Anti-cancer agent composition
12/27/2012WO2012176804A1 Glucopyranosyloxypyrazole derivative
12/27/2012WO2012176792A1 Pharmaceutical composition for inflammatory diseases, allergic diseases and autoimmune diseases
12/27/2012WO2012176763A1 Novel indazole derivative
12/27/2012WO2012176668A1 Lidocaine-containing cataplasm
12/27/2012WO2012176651A1 Novel anti-tumor agent, and method for screening for novel anti-tumor agent
12/27/2012WO2012176438A1 Sedative agent for vaporization and inhalation, and sedative perfume composition containing same
12/27/2012WO2012176282A1 Apoptosis-inducing agent
12/27/2012WO2012176175A1 New uses of nanog inhibitors and related methods
12/27/2012WO2012176163A2 Compounds for the treatment of cancers associated with human papillomavirus
12/27/2012WO2012176155A1 Pharmaceutical composition for use against inflammation and pain
12/27/2012WO2012176149A1 Treatment of hepatitis c virus
12/27/2012WO2012176143A1 Pharmaceutical composition comprising a trpa1 antagonist and a beta-2 agonist
12/27/2012WO2012176140A1 Process for the preparation of dexlansoprazole
12/27/2012WO2012176131A1 Compositions and methods useful for treating pediculosis
12/27/2012WO2012176123A1 3 - imidazolyl- indoles for the treatment of proliferative diseases
12/27/2012WO2012176105A1 Pharmaceutical composition comprising a trpa1 antagonist and a leukotriene receptor antagonist
12/27/2012WO2012176066A1 Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophrenia
12/27/2012WO2012176061A1 Trpv1 antagonists including dihydroxy substituent and uses thereof
12/27/2012WO2012176025A1 Pva-boronic acid containing copolymer compositions for protein delivery
12/27/2012WO2012176024A1 Cryogels of pva-boronic acid containing co-polymers for cell culture
12/27/2012WO2012176015A1 Methods for treating uv-damaged skin and scc tumors and for removing tattoos with topical ingenol mebutate
12/27/2012WO2012176009A1 Treatment and prevention of diseases related to oxidative stress
12/27/2012WO2012175991A1 Fused pentacyclic anti - proliferative compounds
12/27/2012WO2012175973A1 Combination treatment comprising a hdac6 inhibitor and an akt inhibitor
12/27/2012WO2012175949A2 Method and apparatus for the production of an arabinoxylan-enriched preparation and other co-products
12/27/2012WO2012175894A1 Pharmaceutical composition for treating dependency in human beings
12/27/2012WO2012175881A1 Topical film-forming composition, and use thereof for treating mycoses
12/27/2012WO2012175813A1 Multivalent [beta] - 1 - 2 - linked mannose oligosaccharides as immunostimulatory compounds and uses thereof
12/27/2012WO2012175798A2 Combination therapy
12/27/2012WO2012175747A1 Production method and dosage form
12/27/2012WO2012175735A1 A20 inhibitors for the treatment of respiratory viral infections
12/27/2012WO2012175733A1 Hcv combination therapy
12/27/2012WO2012175730A1 10h-benzo[g]pteridine-2,4-dione derivatives, method for the production thereof, and use thereof
12/27/2012WO2012175729A1 10h-benzo[g]pteridine-2,4-dione derivatives, method for the production thereof, and use thereof
12/27/2012WO2012175715A1 Piperazine derivatives, methods for preparing same, and uses thereof in the treatment of insulin resistance
12/27/2012WO2012175714A1 Phenylbutyrate in rectal form for the treatment of a motor neuron disease or a metabolic disease
12/27/2012WO2012175707A1 Piperazine derivatives, methods for preparing same, and uses thereof in the treatment of insulin resistance
12/27/2012WO2012175706A1 Use of 10h-benzo[g]pteridine-2,4-dione derivatives
12/27/2012WO2012175702A1 Rimfampicin analogue useful for infection imaging
12/27/2012WO2012175698A1 Therapeutic use of all-trans retinoic acid (atra) in patients suffering from alcoholic liver disease
12/27/2012WO2012175659A1 N-acetyl cysteine and composition thereof for use in the treatment of vaginal pathologies
12/27/2012WO2012175654A1 Tetraline sulfonamide derivatives for use in the treatment of proliferative disorders
12/27/2012WO2012175608A1 Method for manufacturing hydroxyethyl starch derivatives
12/27/2012WO2012175594A1 Wheat germ extract obtained by protease hydrolysis and medical use thereof
12/27/2012WO2012175591A1 Heterocyclyl aminoimidazopyridazines
12/27/2012WO2012175587A2 Novel crystalline cefoperazone intermediate
12/27/2012WO2012175581A1 Antiviral compounds
12/27/2012WO2012175541A1 Deuterium-enriched 4-hydroxy-5-methoxy-n,1-dimethyl-2-oxo-n-[(4-trifluoro-methyl)phenyl]-1,2-dihydroquinoline-3-carboxamide
12/27/2012WO2012175531A1 Method of administration of 4-((1r,3s)-6-chloro-3-phenyl-indan-1-yl)-1,2,2-trimethyl-piperazine and the salts thereof in the treatment of schizophrenia
12/27/2012WO2012175522A1 Polymorphs of (s)-pyrrolidine-1,2-dicarboxylic acid 2-amide 1-({4-methyl-5-[2-(2,2,2-trifluoro-1,1-dimethyl-ethyl)-pyridin-4-yl]-thiazol-2-yl}-amide
12/27/2012WO2012175520A1 Hydroxy substituted isoquinolinone derivatives
12/27/2012WO2012175518A1 Vaccine adjuvant composition comprising inulin particles
12/27/2012WO2012175516A1 New family of analogues and nadp+ or nadph, their preparation and their application in therapeutics
12/27/2012WO2012175514A1 Pyridinone derivatives and pharmaceutical compositions thereof
12/27/2012WO2012175487A1 Cyclohexyl isoquinolinone compounds
12/27/2012WO2012175434A1 Pharmaceutical formulations comprising vestipitant
12/27/2012WO2012175357A1 Modulation of microrna-138 for the treatment of bone loss
12/27/2012WO2012175354A1 Dialysis precursor composition
12/27/2012WO2012175353A1 Dialysis precursor composition
12/27/2012WO2012175168A1 7-azaindole derivatives suitable for treatment of cancers
12/27/2012WO2012175085A1 Tobacco chewing gum formulation
12/27/2012WO2012175052A1 Sensitizer for reversing or reducing radiotherapy resistance in cases of esophageal carcinoma, screening method and use thereof
12/27/2012WO2012175049A1 Amide compound, preparation method and uses thereof
12/27/2012WO2012175047A1 Use of fluorine-containing, water-soluble platinum complex in preparing medications for preventing and treating tumors
12/27/2012WO2012175046A1 Use of water soluble platinum complex in preparing drugs for prevention and treatment of tumours
12/27/2012WO2012175045A1 Water-soluble fluorine-containing platinum coordination complex for tumour treatment and preparation method thereof
12/27/2012WO2012175044A1 Water-soluble platinum coordination complex for tumour treatment and preparation method thereof
12/27/2012WO2012175031A1 A process for the preparation of prasugrel and several novel crystalline forms of prasugrel hydrochloride
12/27/2012WO2012175002A1 Derivate, preparation method and use of 10-methoxycamptothecine
12/27/2012WO2012174926A1 N-substituted isopropyldimethyl azulene sulfonamide derivatives, and preparation method and use thereof
12/27/2012WO2012174856A1 Oral thrombin inhibitor and preparation method and medical use thereof
12/27/2012WO2012174784A1 Cefuroxime axetil tablet and direct all-powder compression method thereof
12/27/2012WO2012174731A1 Method and improved pharmaceutical composition for improving the absorption of an ester prodrug
12/27/2012WO2012174730A1 Preparative method and use of zyj-d08a and its epimers as histone deacetylase inhibitors
12/27/2012WO2012174699A1 A series of ecteinascidins analogs with anti-tumor effect
12/27/2012WO2012174666A1 Methods for the prognostic and/or diagnostic of neurodegenerative disease, methods to identify candidate compounds and compounds for treating neurodegenerative disease
12/27/2012WO2012154725A3 Steroid-sparing effects of beta-adrenergic inverse agonists and use thereof
1 ... 898 899 900 901 902 903 904 905 906 907 908 909 910 911 912 913 914 915 916 917 918 ... 7860